Back to search results

ViraSafe and BRITE for Suicide Safety Planning in Adolescents

This study is testing two smartphone apps, ViraSafe and BRITE, to help young people aged 13 to 24 who have recently attempted suicide or had thoughts of suicide. These apps aim to improve suicide safety planning, which involves creating a plan to stay safe during difficult times. ViraSafe is an updated version of the BRITE app that includes features to help you and your healthcare provider work together on your safety plan. The study wants to see how much young people use these apps (engagement) over 3 months. This study is currently unclear on its recruitment status and plans to enroll 100 participants.

Study design
This is an interventional study planning to enroll 100 participants. The study is testing two behavioral interventions, ViraSafe and BRITE.
What's involved
Participants will use the ViraSafe or BRITE app, complete a safety plan with their provider, and may be prompted to complete daily distress ratings. The engagement with the apps will be measured for 3 months.
Compensation
Not stated in the trial record.
Follow-up
Participants' engagement with the apps will be measured for 3 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07348666

A Just-in-time Adaptive Intervention for Suicide Safety Planning in Adolescents

Recruiting
NAAges 13–24InterventionalPrevention
Ksana Health
~100 participants
Updated 2026-08-12 on ClinicalTrials.gov
What's tested:ViraSafe: Treatment pushesBRITE

At a glance

Recruiting sites
2 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proximal Engagement
Measured over 24 hours
+1 more outcome measured

Conditions

Suicide
Mental Health Disorder
Anhedonia

Explore related trials

AnhedoniaDepressionMood DisorderPsychiatric DisorderSuicide

Where it's being run

3 sites across 2 states
Pennsylvania2
Oregon1

Who to contact

Stephanie Stepp, PhD
[email protected]
412-383-5051
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

13-17 years old
Suicide attempt in the last year and ideation in the past month
English fluency and literacy
Parent or legal guardian willing and able to legally provide informed consent
Receiving care at one of the study clinical settings with trained providers to onboard ViraSafe or BRITE safety plan
18-24 years old
Recent suicide attempt or ideation with a plan
English fluency and literacy
Receiving care at one of the study clinical settings with trained providers to onboard ViraSafe or BRITE safety plan.

Exclusion

Unable to read/understand English
Current manic or psychotic episode
Development disability precluding comprehension of study procedures
No routine access to a mobile phone, assessed by EHR review and during phone screen
No eligible parent or legal guardian to provide informed consent
Unable to read/understand English
Current manic or psychotic episode
Development disability precluding comprehension of study procedures
No routine access to a mobile phone, assessed by EHR review and during phone screen

What this trial measures

  • Proximal Engagement24 hours

    Engagement with the ViraSafe app (i.e., tapping on the push notification, patterns of accessing app features such as coping skills and safety plan) and BRITE app (daily dose rating, post rating after accessing coping skill, editing coping skill content)

  • Engagement with the apps3 months

    Engagement over the course of the trial will be measured through objective app usage metrics, including total number and frequency of features used.